Medicare Enrolled
Dr. Kenneth Nahum, D.O.
Hematology & Oncology · Howell, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nahum from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nahum?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nahum
Dr. Kenneth Nahum is a hematology & oncology specialist in Howell, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nahum performed 236,034 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Nahum received a total of $3,703 from 52 pharmaceutical and/or device companies across 213 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nahum is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 1% volume in NJ
$3,703 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗236,034
Medicare services
Top 1% in NJ for hematology & oncology
Not available
Unique patients (not deduplicated)
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
56,640 | $0 | $1 |
| Anti-nausea injection (aprepitant) | 31,850 | $1 | $8 |
| Nivolumab injection (Opdivo) | 30,820 | $24 | $73 |
| Pembrolizumab injection (Keytruda) | 28,000 | $43 | $128 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
20,450 | $0 | $23 |
| Denosumab injection (Prolia/Xgeva) | 11,880 | $18 | $58 |
| Iron infusion (Monoferric) | 8,000 | $17 | $63 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
6,361 | $0 | $1 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
4,760 | $6 | $50 |
| Anti-nausea injection (ondansetron/Zofran) | 3,972 | $0 | $3 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
3,867 | $8 | $18 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
3,780 | $23 | $173 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
3,646 | $8 | $31 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
3,420 | $6 | $27 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,210 | $1 | $102 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,853 | $104 | $231 |
| Injection, leucovorin calcium, per 50 mg | 1,825 | $3 | $24 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
1,329 | $25 | $125 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,142 | $68 | $154 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
890 | $65 | $158 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
813 | $114 | $567 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
675 | $1 | $5 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
674 | $1 | $13 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
654 | $11 | $79 |
| Pegfilgrastim-cbqv injection An injection of pegfilgrastim-cbqv, a biosimilar medication, administered at a dose of 0.5 mg. |
540 | $108 | $806 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
512 | $13 | $92 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
439 | $4 | $22 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
399 | $25 | $126 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
359 | $55 | $253 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
339 | $2 | $69 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
317 | $7 | $387 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
297 | $11 | $61 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
262 | $2 | $12 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
230 | $57 | $269 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
229 | $2 | $129 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
219 | $77 | $247 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
207 | $28 | $123 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
172 | $139 | $426 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
169 | $17 | $79 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
145 | $17 | $78 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
142 | $49 | $239 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
120 | $60 | $194 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
86 | $147 | $310 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
76 | $128 | $352 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 75 | $130 | $2,760 |
| New patient office visit, complex (60-74 min) | 70 | $178 | $442 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
33 | $29 | $206 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
27 | $2 | $19 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
25 | $147 | $511 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
19 | $4 | $14 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $28 | $92 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
4.7% high complexity
89.7% medium
5.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,703
Total received (2018-2024)
Avg $529/year across 7 years
Top 47% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
213
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$755
2023
$1,106
2022
$810
2021
$259
2020
$318
2019
$403
2018
$52
Payments by company (2024)
E.R. Squibb & Sons, L.L.C.
$164
Novartis Pharmaceuticals Corporation
$103
Gilead Sciences, Inc.
$82
Eisai Inc.
$69
PFIZER INC.
$49
Daiichi Sankyo Inc.
$48
Astellas Pharma US Inc
$32
Tempus AI, Inc
$29
TAIHO ONCOLOGY, INC.
$21
GENZYME CORPORATION
$18
Stemline Therapeutics Inc.
$18
Janssen Biotech, Inc.
$17
ABBVIE INC.
$16
EMD Serono, Inc.
$16
GlaxoSmithKline, LLC.
$15
Mirati Therapeutics, Inc.
$15
AstraZeneca Pharmaceuticals LP
$15
PUMA BIOTECHNOLOGY, INC.
$14
Merck Sharp & Dohme LLC
$13
Top 3 companies account for 46.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$650
E.R. Squibb & Sons, L.L.C.
$456
Gilead Sciences, Inc.
$349
ABBVIE INC.
$231
PFIZER INC.
$217
Janssen Biotech, Inc.
$180
Merck Sharp & Dohme LLC
$107
Kite Pharma, Inc.
$101
Incyte Corporation
$100
Eisai Inc.
$88
Bayer HealthCare Pharmaceuticals Inc.
$68
Daiichi Sankyo Inc.
$68
GENZYME CORPORATION
$67
GlaxoSmithKline, LLC.
$62
Astellas Pharma US Inc
$61
Celgene Corporation
$58
Seagen Inc.
$56
BeiGene USA, Inc.
$53
Sun Pharmaceutical Industries Inc.
$50
Merck Sharp & Dohme Corporation
$41
Seattle Genetics, Inc.
$38
Stemline Therapeutics Inc.
$38
Regeneron Healthcare Solutions, Inc.
$32
Secura Bio, Inc.
$31
Sumitomo Pharma America, Inc.
$31
ARRAY BIOPHARMA INC
$30
Blueprint Medicines Corporation
$29
Tempus AI, Inc
$29
Pharmacyclics LLC, An AbbVie Company
$29
Coherus Biosciences Inc.
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
TAIHO ONCOLOGY, INC.
$21
MorphoSys, US Inc.
$16
EMD Serono, Inc.
$16
AVEO Pharmaceuticals, Inc.
$15
Mirati Therapeutics, Inc.
$15
AstraZeneca Pharmaceuticals LP
$15
Ipsen Biopharmaceuticals, Inc
$15
Puma Biotechnology, Inc.
$15
Mylan Institutional Inc.
$15
PUMA BIOTECHNOLOGY, INC.
$14
Shire North American Group Inc
$14
Exelixis Inc.
$14
Epizyme, Inc.,
$14
EISAI INC.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$14
Myovant Sciences Inc.
$13
Karyopharm Therapeutics Inc.
$12
Servier Pharmaceuticals LLC
$12
Nestle HealthCare Nutrition Inc.
$12
Lilly USA, LLC
$11
Genentech USA, Inc.
$11
Top 3 companies account for 39.3% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AUGTYRO · AYVAKIT · BOSULIF · BRAFTOVI · BRUKINSA · CERDELGA · COPIKTRA · Cabometyx · DARZALEX · ELIQUIS · ERLEADA · Enhertu · FARYDAK · FOTIVDA · Fabhalta · GILOTRIF · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · Imbruvica · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · Lenvima · MEKINIST · MONJUVI · Nerlynx · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Ogivri · Orserdu · PROMACTA · Pomalyst · Rituxan Hycela · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECVAYLI · TIBSOVO · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VPRIV · Vyloy · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZENPEP
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
52
County median income
$122,727
Nearest hospital to ZIP centroid (approximate)
MONMOUTH MEDICAL CENTER-SOUTHERN CAMPUS
5.0 mi
5.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nahum is a mixed practice specialist, with above-average Medicare volume (top 1% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nahum experienced with filgrastim injection (zarxio) for white blood cells?
Based on Medicare claims data, Dr. Nahum performed 56,640 filgrastim injection (zarxio) for white blood cells services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Nahum receive payments from pharmaceutical companies?
Yes. Dr. Nahum received a total of $3,703 from 52 companies across 213 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nahum's costs compare to other hematology & oncology specialists in Howell?
Dr. Nahum's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nahum) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Howell
Browse hematology & oncology specialists in Howell ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology